Javascript must be enabled to continue!
Influence of hepatitis delta virus superinfection on the clearance of hepatitis B virus (HBV) markers in HBV carriers in Japan
View through CrossRef
AbstractTo elucidate the influence of hepatitis delta virus (HDV) superinfection on the clearance of hepatitis B virus (HBV) associated antigens in HBV carriers, we examined for antibody to hepatitis delta antigen (anti‐HD) serial sera collected from 1,029 HBV carriers in Kure, Japan. Of the 242 HBV carriers with hepatitis B e antigen (HBeAg), 28 became seropositive for anti‐HD, of whom 18 (64.3%) cleared HBeAg; 214 did not become seropositive for anti‐HD, of whom 70 (32.7%) cleared HBeAg. Thus, HBeAg clearance was observed in a significantly higher proportion of HDV‐superinfected carriers as compared with carriers with‐ out HDV infection (P< 0.005). In the 56 HBV carriers who cleared hepatitis B surface antigen (HBsAg), anti‐HD was detected in three cases with increased serum alanine aminotransferase activity preceding HBsAg clearance. The duration of anti‐HD seropositive state was less than 5 years, and the titer of anti‐HD was relatively low in every case. These data suggest that the HDV infection rate in Japan is higher than previously reported, that HDV superinfection can be one of the factors that induce the HBeAg clearance and HBsAg clearance in HBV carriers, and also that the most likely outcome of HDV superinfection in HBV carriers in Japan may be acute self‐limited infection.
Title: Influence of hepatitis delta virus superinfection on the clearance of hepatitis B virus (HBV) markers in HBV carriers in Japan
Description:
AbstractTo elucidate the influence of hepatitis delta virus (HDV) superinfection on the clearance of hepatitis B virus (HBV) associated antigens in HBV carriers, we examined for antibody to hepatitis delta antigen (anti‐HD) serial sera collected from 1,029 HBV carriers in Kure, Japan.
Of the 242 HBV carriers with hepatitis B e antigen (HBeAg), 28 became seropositive for anti‐HD, of whom 18 (64.
3%) cleared HBeAg; 214 did not become seropositive for anti‐HD, of whom 70 (32.
7%) cleared HBeAg.
Thus, HBeAg clearance was observed in a significantly higher proportion of HDV‐superinfected carriers as compared with carriers with‐ out HDV infection (P< 0.
005).
In the 56 HBV carriers who cleared hepatitis B surface antigen (HBsAg), anti‐HD was detected in three cases with increased serum alanine aminotransferase activity preceding HBsAg clearance.
The duration of anti‐HD seropositive state was less than 5 years, and the titer of anti‐HD was relatively low in every case.
These data suggest that the HDV infection rate in Japan is higher than previously reported, that HDV superinfection can be one of the factors that induce the HBeAg clearance and HBsAg clearance in HBV carriers, and also that the most likely outcome of HDV superinfection in HBV carriers in Japan may be acute self‐limited infection.
Related Results
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Modulation of HBV infection and replication by cell-derived factors
Modulation of HBV infection and replication by cell-derived factors
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT REQUEST OF AUTHOR.] Hepatitis B virus (HBV) infection is one of the most serious health problems. HBV infection leads to serious...
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
To evaluate the factors determining the severity of chronic hepatitis B virus infection and the interactions of human immunodeficiency virus and hepatitis delta virus infections, w...
Abstract P1-15-02: Low incidence of hepatitis B reactivation after chemotherapy in Japanese breast cancer patients with resolved HBV
Abstract P1-15-02: Low incidence of hepatitis B reactivation after chemotherapy in Japanese breast cancer patients with resolved HBV
Abstract
Background: Recently, chemotherapy-induced reactivation of hepatitis B virus (HBV) has been reported not only in patients with HBV surface antigen positive ...
Oxidative stress sensor Keap1 recognizes HBx protein to activate the Nrf2/ARE signaling pathway, thereby inhibiting hepatitis B virus replication
Oxidative stress sensor Keap1 recognizes HBx protein to activate the Nrf2/ARE signaling pathway, thereby inhibiting hepatitis B virus replication
ABSTRACT
Hepatitis B virus (HBV) infection promotes reactive oxygen species production while paradoxically inducing the expression of antioxidant enzymes. HBV-induced dis...
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patient...
HBV Prophylaxis through vaccination in Romanian dental professionals exposed to Toxoplasma gondii
HBV Prophylaxis through vaccination in Romanian dental professionals exposed to Toxoplasma gondii
Background: Blood borne diseases are important diseases that can transmit their etiological
agents in the medical office. One of the most feared due to its contagious remains hepat...
QUANTITATION OF HBV DNA BY REALTIME PCR FOR HBV DETECTION AND FOLLOW-UP VIRAL LOAD IN PATIENTS WITH CHRONICHBV HEPATITIS USING ANTIVIRAL DRUGS
QUANTITATION OF HBV DNA BY REALTIME PCR FOR HBV DETECTION AND FOLLOW-UP VIRAL LOAD IN PATIENTS WITH CHRONICHBV HEPATITIS USING ANTIVIRAL DRUGS
Background: Real-time PCR assay has been routinely used in many laboratories for HBV determination and follow –up of the HBV DNA levels in serum of chronic HBV patients during anti...

